The Pharmacy Times® Retail Clinical Role section is a comprehensive resource for clinical news and expert insights on issues pertaining to retail, community, and independent pharmacists.
April 28th 2025
No matter what role you are in as a pharmacist, no matter where you work or how long you have been practicing, understand that making a difference in the life of a patient matters.
Understanding the Expanding Business of 'Well'
August 26th 2019Attendees at the NACDS Total Store Expo in Boston had a chance to hear about the changing landscape of wellness, in a presentation titled “How To Get Your Share of the Big Business of WELL,” presented by representatives from WSL Strategic Retail.
Read More
Study Predicts Potential Measles Outbreaks in Texas
August 25th 2019A recent study suggests that vaccination rates in some Texas schools are low enough to allow for large measles outbreaks, but limiting vaccine exemptions could decrease this risk. Vaccine exemptions, which allow unvaccinated children to attend school, have increased by a factor of 28 since 2003 in Texas.
Read More
Independent Corner: Interacting with Health Systems
August 22nd 2019Community Pharmacy Consultant Bruce Kneeland speaks with Kevin DeMass, RPh, President of Apothecary Shoppe, Salt Lake City, UT, discusses how the pharmacy staff interacts with physicians, health care providers, and payers on a daily basis.
Watch
FDA Issues Warning Letter to OTC Drug Manufacturer For Data Integrity Concerns
August 21st 2019The FDA has published a warning letter sent to Ningbo Huize Commodity, an over-the-counter drug manufacturer, citing significant current good manufacturing practice (CGMP) violations including data integrity issues.
Read More
Survey: Customer Satisfaction With Pharmacists Remain High
August 21st 2019Despite e-commerce disruptions to the industry, a recent study found that the United States pharmacy industry continues to maintain high levels of customer satisfaction in both the brick-and-mortar and mail order segments.
Read More
New Treatment for Rheumatoid Arthritis Granted FDA Approval
August 19th 2019Officials with the FDA have approved AbbVie’s upadacitinib (Rinvoq) 15 mg, once-daily oral Janus kinase (JAK) inhibitor, for the treatment of adults with moderately to severely active rheumatoid arthritis (RA) who have had an inadequate response or intolerance to methotrexate (MTX-IR).
Read More
August 16 Week in Review: Noninvasive Bladder Cancer Test; Mental Health Genetic Testing Services
August 16th 2019This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings, and more. Our Week in Review is a can't miss for the busy pharmacy professional.
Watch